A carregar...
Evaluating the usability and safety of the semaglutide single‐dose pen‐injectors through summative (human factors) usability testing
AIMS/INTRODUCTION: A single‐dose, shield‐activated pen‐injector for each of the three approved dose variants (0.25, 0.5 and 1 mg) of once‐weekly subcutaneous semaglutide has been developed to improve usability. This analysis presents findings from the summative usability testing process for the sing...
Na minha lista:
| Publicado no: | J Diabetes Investig |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8169358/ https://ncbi.nlm.nih.gov/pubmed/33034163 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.13429 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|